Welcome

United States Antifungal Prescription Pharmaceutical Markets

 

  • Research Code : 5572-01-00-00-00
  • SKU : HC00236-NA-MR_03214
  • Share this :
  • Release Date : 18-Nov-1999
  • Region : North America
  • Request Study Sample

Availability: In stock

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

Pay By Invoice

Be the first to review this product



Table of Contents

United States Antifungal Prescription Pharmaceutical Markets, Executive Summary

Introduction to the U.S. Prescription Antifungal Market

Introduction to the U.S. Prescription Antifungal Market
Objectives and Purpose
Report Scope and Segmentation
Disease Overview: Fungi as Human Pathogens
Fungal Infection Overview
Patient Population Overview
Report Structure

Summary of Major Findings

Market Drivers and Restraints
Total Revenue and Revenue Growth Rates
Percent of Total Revenues by Product Type
Analysis by Major Segment
Competitive Analysis
Conclusion

United States Antifungal Prescription Pharmaceutical Markets, Market Engineering Research Methodology

Frost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare Industry

Frost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare Industry

Research Sources

Secondary Sources
Primary Research

Pharmaceutical Forecast Model

Pharmaceutical Forecast Model
Population-Based Forecast
Product-Based Forecast
Market Model Assumptions
Research Limitations

Presentation of Market Engineering Measurements, Definition and their Strategic Significance

Presentation of Market Engineering Measurements, Definition and their Strategic Significance

Glossary of Terms

List of Definitions
List of Acronyms

United States Antifungal Prescription Pharmaceutical Markets, Challenges in the U.S. Prescription Antifungal Market

Identification of Challenges Facing the U.S. Prescription Antifungal Market

Identification of Challenges Facing the U.S. Prescription Antifungal Market

Industry Challenges

Discovering Novel Drugs with Less Toxic Profiles Determines Future Market Leaders
Under-Reporting of Mycotic Infections Undermines Market Growth and Direction of Antifungals
Lack of Sensitive Diagnostic Methods Negatively Impacts Number of Diagnosed Patients
Reduced Drug Interaction Profiles Positively Impacts Product Penetration
Increased Understanding of Fungal Cell Function and Proliferation Will Create Novel Mechanisms of Attack
Growing Resistance of Candida Isolates May Incapacitate Effectiveness of Antifungals
Increased Long-Term Patient Data Propels Greater Prescribing for Newly Marketed Drugs
Persistent Collaboration Between Industry and Public Health Organizations Boosts Awareness of Mycoses Issues
Emergence of New Pathogens Will Present New Drug Resistance Challenges with Currently Used Antifungal Drugs

Market Engineering Research for the U.S. Polyene Antifungal Market

Market Overview and Definitions

Overview
Definition
Scope/Segmentation
History
Indication Overview

Market Engineering Measurement System

Market Engineering Measurement System

Market Drivers

Market Drivers
Increasing Number of Immunocompromised Patients Drives Growth of Antifungal Therapy
Safer Profile of Novel Polyene Drugs Expedites Product Uptake
Prophylaxis Indication Offers Future Growth Prospects
Clinical Trials Supports Use of Novel Products
Aggressive Promotional Campaigns Drive Market Growth
Early Discharge from Hospitals Increases Volume of Treatable Patients with Fungal Infections
Triazole Resistance Drives Physicians to Seek Alternatives

Market Restraints

Market Restraints
High Treatment Costs Restrict Market Potential
Physicians’ Hesitancy to Prescribe Slows Uptake of Novel Products
Increasing Competition from Emerging Therapies Slows Market Growth of Novel Products

Market Engineering Revenue Forecasts (1995-2005)

Patient Population (Demand Analysis)
Pricing Analysis
Revenues
Revenue Trends
Technology Trends

Competitive Analysis

Competitive Structure
Competitive Factors
Mergers, Alliances, and Acquisitions
Market Share Analysis
Market Share Winners and Why
Market Share Losers and Why

Product Analysis

Products on the Market
Products in Clinical Trials
Products in Development

Market Engineering Research for the U.S. Prescription Triazole Market

Market Overview and Definitions

Overview
Definitions and Product Overview
Scope/Segmentation
History
Indication Overview

Market Engineering Research Measurement System

Market Engineering Research Measurement System

Market Drivers

Market Drivers
Expanding Immunocompromised Market Base Increases Demand for Antifungals
Favorable Studies in Children Boosts Prescriptions
Absence of Standard Prophylaxis Antifungal Therapy Creates Need in a Largely Unclaimed Market
Direct-to-Consumer Advertising Supplementation Increases Public Awareness and Prescriptions
Novel Triazole Agents Benefit from Fluconazole Resistance Concerns

Market Restraints

Market Restraints
Patent Expiration of Blockbuster Triazoles Prompts Significant Shrinkage in Market Growth
Negative Perceptions of Drug Resistance Hampers Market Uptake
Declining Incidence of HIV-Related Fungal Infections Reduces Market Potential of Antifungals

Market Engineering Revenue Forecasts (1995-2005)

Patient Population (Demand Analysis)
Pricing Analysis
Revenues
Technology Trends

Competitive Analysis

Competitive Structure
Competitive Factors
Mergers, Alliances, and Acquisitions
Market Share Analysis
Market Share Winners and Why
Market Share Losers and Why

Product Analysis

Products on the Market
Products in Clinical Development
Products in Development

Market Engineering Research for the U.S. Prescription Imidazole Market

Market Overview and Definitions

Overview
Definition
Scope/Segmentation
History
Indication Overview

Market Engineering Research Measurement System

Market Engineering Research Measurement System

Market Drivers

Market Drivers
Growth in Infection-Prone Age Cohorts Increase Potential Patient Population
OTC Drugs Have Brought Infection Awareness to Public
Expanding Immunocompromised Patient Base Drives Demand for Antifungals
Lower Costs Keep Imidazole Drugs a Viable Option

Market Restraints

Market Restraints
Shorter Treatment Regimens of OTC Products Decreases the Need for Prescription Therapies
Preference to Self-Diagnose by End-Users Decreases Demand for Prescription Products
Generic Imidazoles Decrease Branded Product Market Shares
Imidazole-Triazole Inverse Relationship Decreases Imidazole Prescriptions in Hospitals
Adverse Drug Interaction Profile Detracts Usage from Specific Patient Populations
Fungal Resistance to Imidazoles Reduces Market Potential

Market Engineering Revenue Forecasts (1995-2005)

Patient Population (Demand Analysis)
Pricing Analysis
Revenues

Competitive Analysis

Competitive Structure
Competitive Factors
Mergers, Alliances, and Acquisitions
Market Share Analysis
Market Share Winners and Why
Market Share Losers and Why

Product Analysis

Products on the Market
Products in Clinical Trials
Products in Development

Market Engineering Research for the U.S. Other Prescription Antifungals Market

Market Overview and Definitions

Overview
Definition
Drug Overview
Scope/Segmentation
History
Indication Overview

Market Engineering Research Measurement System

Market Engineering Research Measurement System

Market Drivers

Market Drivers
Patient Population Customer Base Expanding
Novel Product Classes Gather Focus on Different Mechanisms of Attack; Displaying a Superior Profile over Imidazoles
Emerging Product Classes to Increase Total Market
Effective Therapies from Novel Product Classes Have Potential Prophylactic Applications
DTC Programs Educating Public of Nail Infections Increases Total Market

Market Restraints

Market Restraints
Self-Diagnosis by End-Users Increases Demand for OTC Fungal Medications Promoting Prescription-to-OTC Switches
Brand Loyalty May Hinder Success for Emerging Products

Market Engineering Unit and Revenue Forecasts (1995-2005)

Patient Population (Demand Analysis)
Pricing Analysis
Revenues

Competitive Analysis

Competitive Structure
Competitive Factors
Mergers, Alliances, and Acquisitions
Market Share Analysis
Market Share Winners and Why
Market Share Losers and Why

Product Analysis

Products on the Market
Products in Clinical Trials
Products in Development


Sample Study






Related Research
WHY CHOOSE
FROST & SULLIVAN
RESEARCH ?

1. Primary Research

Our analysis is based on comprehensive primary research conducted with core market participants.

2. Global Coverage

Unparalleled coverage of geographies, our analyst & consultant teams are based in 42+ offices spanning the globe.

3. Breadth of Vertical Industries

We cover the broadest spectrum of markets to provide our clients with the most relevant analysis and transformational insights.

4. Visionary Innovation Research

With on-going transformational shifts, our visionary innovation research prepares you with information on key megatrends shaping the future of your industry.

5. Mega Trends

Mega Trends are global forces that transform business, societies and economies.

6. Convergence Research Coverage

Taking an approach of analysing a macro-to-micro impact, our convergence research helps you prepare against an impending 'Kodak moment'.